Efficacy and safety of abciximab versus tirofiban in addition to ticagrelor in STEMI patients undergoing primary percutaneous intervention

Autor: Pablo Revilla-Martí, Jose A. Linares-Vicente, Ana Martínez Labuena, Octavio Jiménez Melo, Paula Morlanes Gracia, Daniel Meseguer González, Antonela Lukic, Borja Simó Sánchez, Jose R. Ruiz Arroyo

Publikováno v: Platelets, Vol 33, Iss 2, Pp 265-272 (2022)

Platelet glycoprotein IIb/IIIa inhibitors (GPIs) have been part of the adjuvant treatment of acute coronary syndrome for years. However, real-life data regarding the efficacy and safety of GPIs under the current indications are lacking in the setting

Externí odkaz: https://doaj.org/article/35a959876cd34b0b811d723065c368df

Resultado a los 5 años del balón de corte o incisión en el tratamiento de la reestenosis de stent coronario con balón farmacoactivo

Autor: José Antonio Linares Vicente, José Ramón Ruiz Arroyo, Antonela Lukic, Borja Simó Sánchez, Octavio Jiménez Melo, Adrián Riaño Ondiviela, Paula Morlanes Gracia, Pablo Revilla Martí

Publikováno v: REC: Interventional Cardiology, Vol 4, Iss 1, Pp 12-18 (2022)

RESUMEN Introducción y objetivos: El uso de balón farmacoactivo (BFA) es una estrategia efectiva en el tratamiento de la reestenosis de stents coronarios (RIS). La modificación neointimal con balón de corte (BC) o incisión junto con BFA se asoci

Externí odkaz: https://doaj.org/article/ce6cf8dc3496451cbd8ab13b66748d11

Case Report: A Novel NKX2-5 Mutation in a Family With Congenital Heart Defects, Left Ventricular Non-compaction, Conduction Disease, and Sudden Cardiac Death

Autor: Paula Morlanes-Gracia, Guido Antoniutti, Jorge Alvarez-Rubio, Laura Torres-Juan, Damian Heine-Suñer, Tomás Ripoll-Vera

Publikováno v: Frontiers in Cardiovascular Medicine, Vol 8 (2021)

The NKX2-5 gene encodes for a transcription factor crucial for cardiac cell differentiation and proliferation. It was the first gene associated with congenital heart disease (CHD) in humans and has been linked to conduction disorders or cardiomyopath

Externí odkaz: https://doaj.org/article/b905495d5aa342b4af447710524ba1fc

[Anti-smoking intervention in the acute phase of acute coronary syndrome: Is there additional benefit in patients included in a cardiac rehabilitation program?]

Autor: Jimeno Sánchez J; Hospital Universitario Miguel Servet, Zaragoza, España. Electronic address: javierjimeno1@gmail.com., Chabbar Boudet MC; Hospital Universitario Miguel Servet, Zaragoza, España; Hospital Nuestra Señora de Gracia, Zaragoza, España., Morlanes Gracia P; Hospital Clínico Universitario Lozano Blesa, Zaragoza, España., Laita Monreal S; Hospital Royo Villanova, Zaragoza, España., López Perales CR; Hospital Universitario Miguel Servet, Zaragoza, España., Cuko G; Hospital Nuestra Señora de Gracia, Zaragoza, España., Albarrán Martín C; Hospital Nuestra Señora de Gracia, Zaragoza, España; Hospital Clínico Universitario Lozano Blesa, Zaragoza, España., Garza Benito F; Hospital Nuestra Señora de Gracia, Zaragoza, España; Hospital Royo Villanova, Zaragoza, España.

Publikováno v: Journal of healthcare quality research [J Healthc Qual Res] 2023 Mar-Apr; Vol. 38 (2), pp. 105-111. Date of Electronic Publication: 2022 Aug 03.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.